Skip to main content
EnglishEN
European Commission logo print header

Minimum viable product for automated 3D imaging reconstruction of the bladder and the bladder cancer

Project description

DEENESFRITPL

3D bladder image reconstruction in real time

Medical imaging with non-ionising radiation such as ultrasound is an attractive means of cancer diagnosis and monitoring mainly due to its safe and non-invasive nature. However, imaging reconstruction is time-consuming and technically challenging to be performed in real time. The EU-funded AIR3D project will promote software that combines ultrasound and photoacoustic images to produce a 3D reconstruction of the bladder in a fast and user-friendly manner. The team will validate the pre-commercial prototype and identify potential clients interested in the software. Overall, implementation of this image analysis approach is expected to improve the diagnosis and clinical monitoring of bladder cancer.

Objective

AIR3D will validate the business potential of the automatic 3D imaging reconstruction software developed within the EDIT FET project. Such software allows performing fast, non-invasive 3D visualization of several information on the bladder in real-time with user friendly interaction with the operator. It combines pre-clinical information from Ultra Sound (US) and Photoacoustic (PA) imaging towards the early diagnosis of bladder cancer and monitoring of cancer progress during therapy and follow-up. Ultrasound (US) and PA imaging are non-invasive non-ionizing technologies, but imaging reconstruction methods are still time-consuming (in particular for high-volume organ as bladder), being manual or semi-manual processes and requiring well trained people.
Nowadays bladder cancer is the ninth most common malignancy globally, with an estimated 430.000 new diagnoses annually, while it has the highest lifetime treatment costs per patient of all cancers. The successful adoption of the software by the market will improve early diagnosis of cancer and better monitoring of the efficacy of ongoing therapies (more accurate and precise 3D images available immediately), as consequence the software will have both societal and economic impact, improving the quality of life of millions of people while reducing social costs and costs of care centres in image processing (no high-skilled personnel needed).
During AIR3D, owners of the EDIT software (LIME and OSR) will be supported by and advisory company (META) to define the best exploitation model for the commercialisation of the software and validate it through the use of the Lean Start up approach. Interaction with relevant stakeholders are foreseen for the validation of the pre-commercial prototype (testing at early adopters’ premises), raise the interest of potential clients (presenting the prototype at international events) and raise funding for scale up and clinical development (pitching in front of investors).

Fields of science

Keywords

Programme(s)

Topic(s)

Call for proposal

H2020-FETOPEN-2018-2020

See other projects for this call

Sub call

H2020-FETOPEN-2018-2019-2020-4

Funding Scheme

CSA - Coordination and support action

Coordinator

LIME TECHNOLOGY IKE
Net EU contribution
€ 45 000,00
Address
PARODOS ARCHIEPISKOPOU MAKARIOU 0
452 21 IOANNINA
Greece

See on map
SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Yes
Region
Βόρεια Ελλάδα Ήπειρος Ιωάννινα
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
No data

Participants (2)

Share this page

Download

Last update: 28 December 2023

My Booklet

Permalink: https://cordis.europa.eu/project/id/101034880

European Union, 2024